Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda [1]

Journal of Internal Medicine

Volumn 255, Issue 6, 2004, Pages 684-688

  Harper, P ^a   Floderus, Y ^a   Holmstrom P ^a   Eggertsen, G ^a   Gafvels M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; GENOMIC DNA; HFE PROTEIN; IRON; TRANSFERRIN;

ALLELE; CHI SQUARE TEST; CONTROLLED STUDY; DNA FLANKING REGION; FAMILIAL DISEASE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFORMED CONSENT; IRON OVERLOAD; LETTER; MAJOR CLINICAL STUDY; ONSET AGE; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 2542611387     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01309.x     Document Type: Letter

References (23)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Valle D, Sly WS. eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 2991-3062.
2. Elder GH, Roberts AG. Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 1995; 27: 207-14.
3. Lundvall O, Weinfeld A, Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand 1970; 1-2: 37-53.
4. Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH, Kushner JP. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989; 97: 972-81.
5. Lundvall O. The effect of phlebotomy therapy in porphyria cutanea tarda. Acta Med Scand 1971; 189: 33-49.
6. Thunell S, Harper P. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda - suggestions for a handling programme. Scand J Clin Lab Invest 2000; 60: 561-79.
7. Simon M. HLA-linked hemochromatosis and sporadic porphyria cutanea tarda. Gastroenterology 1986; 90: 800-1.
8. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
9. Roberts AG, Whatley SD, Nicklin S et al. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 1997; 25: 159-61.
10. Santos M, Clevers HC, Marx JJ. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda [letter]. N Engl J Med 1997; 336: 1327-8.
11. Stuart KA, Busfield F, Jazwinska EC et al. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
12. Sampietro M, Piperno A, Lupica L et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda [see comments]. Hepatology 1998; 27: 181-4.
13. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.
14. Christiansen L, Bygum A, Thomsen K, Brandrup F, Horder M, Petersen NE. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem 1999; 45: 2025-6.
15. Tannapfel A, Stölzel U, Köstler E et al. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients. Virchows Arch 2001; 439: 1-5.
16. Bulaj ZJ, Phillips JD, Ajioka RS et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-71.
17. Holmström P, Marmur J, Eggertsen G, Gåfvels M, Stål P. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 2002; 51: 723-30.
18. De Verneuil H, Sassa S, Kappas A. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem 1983; 258: 2454-60.
19. Elder GH, Wyvill PC. Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction. Enzyme 1982; 28: 186-95.
20. de Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea. Two different diseases. Hum Genet 1978; 44: 145-51.
21. von Ahsen N, Wieland E, Adjarov D, Krastev Z, Oellerich M, Ivanova A. The HFE gene S65C polymorphism is rare among Bulgarian porphyria cutanea tarda patients. J Hepatol 2001; 34: 484-8.
22. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
23. Brady JJ, Jackson HA, Roberts AG et al. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. J Invest Dermatol 2000; 115: 868-74.